HC Wainwright Reaffirms “Buy” Rating for Protagonist Therapeutics (NASDAQ:PTGX)
HC Wainwright restated their buy rating on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research note released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $80.00 price objective on the stock. Other research analysts have also recently issued reports about the stock. BTIG Research set a $73.00 price objective on shares […]
HC Wainwright restated their buy rating on shares of Protagonist Therapeutics (NASDAQ:PTGX – Free Report) in a research note released on Tuesday morning,Benzinga reports. HC Wainwright currently has a $80.00 price objective on the stock. Other research analysts have also recently issued reports about the stock. BTIG Research set a $73.00 price objective on shares […]
